MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ccd.22473

Медицинская библиотека · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2010

Preliminary results of the INSPIRE trial with the novel MGuard stent system containing a protection net to prevent distal embolization.

Maia Felipe, Costa J Ribamar, Abizaid Alexandre, Feres Fausto, Costa Ricardo, Staico Rodolfo, Siqueira Dimytri, Esteves Vinicius, Sousa Amanda, Sousa J Eduardo

Клиническое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To assess the efficacy of the MGuard(TM) stent combining a polymer-mesh sleeve attached to the external surface of a bare-metal stent in preventing distal embolization during percutaneous coronary intervention (PCI).

BACKGROUND

Distal embolization of thrombus/platelet aggregates is associated with worse immediate and long-term prognosis after PCI. Treatment of saphenous vein graft (SVG) and PCI in the setting of acute coronary syndromes (ACS) is often related to this complication. Although protection and aspiration devices have been shown to reduce distal embolization, they add time and cost to PCI.

METHODS

A total of 30 patients were included. Inclusion criteria were de novo lesions in SVG or native vessels with angiographic evidence of instability with potential to provoke flow disturbances and/or distal embolization. Primary endpoint included the incidence of major adverse cardiac events (MACE) (composite of cardiac death, non-fatal myocardial infarction and TLR) up to 30 days of the procedure and TIMI flow right after the PCI.

RESULTS

Mean population age was 60.8 years with 36.7% of diabetes. Overall, 53.3% presented with ACS, and most lesions were located in SVG (16 of 30). The majority of lesions had complex morphology including the presence of thrombus (30%) and ulcer (33.3%). The MGuard stent was successfully deployed in all cases with no angiographic/clinical complications including distal embolization. Final TIMI-3/blush-3 were achieved in all cases with no MACE up to 30 days of the procedure.

CONCLUSIONS

In this preliminary evaluation, the MGuard device demonstrated excellent performance in a highly complex lesion subset, including absence of angiographic/procedural complications, and no adverse events up to 30-day FU.

Для цитирования: Maia Felipe, Costa J Ribamar, Abizaid Alexandre, Feres Fausto, Costa Ricardo, Staico Rodolfo, Siqueira Dimytri, Esteves Vinicius, Sousa Amanda, Sousa J Eduardo. Preliminary results of the INSPIRE trial with the novel MGuard stent system containing a protection net to prevent distal embolization.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2010. DOI: 10.1002/ccd.22473.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.